Bayer (BAYRY.PK -2%) and Regeneron (REGN -1%) lose their U.K. patent fight on Eylea, a potential blockbuster VEGF Tarp-Eye treatment produced jointly by the two companies. A London Court has ruled that the drug infringes a patent held by Roche (RHHBY.PK -1.4%) subsidiary Genentech.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Investor's Business Daily (Feb 23, 2015)
at CNBC.com (Oct 27, 2014)
at Fox Business (Apr 29, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs